
Mark O'Connor MD
Adult Congenital Heart Disease, Cardiac Electrophysiology
Physician
Join to View Full Profile
2409 Cherry StSte 100Toledo, OH 43608
Phone+1 419-251-3700
Fax+1 419-251-3835
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark O'Connor, MD is a cardiologist in Toledo, Ohio. He is currently licensed to practice medicine in Ohio, Michigan, and Illinois.
Education & Training
- University of MichiganFellowship, Cardiovascular Disease, 1991 - 1993
- University of WashingtonResidency, Internal Medicine, 1986 - 1989
- University of Michigan Medical SchoolClass of 1986
Certifications & Licensure
- MI State Medical License 1997 - 2028
- OH State Medical License 1997 - 2026
- IL State Medical License 1993 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 51 citationsAnti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cellsHee Jun Kim, Ahrum Min, Seock-Ah Im, Hyemin Jang, Kyung Hun Lee
International Journal of Cancer. 2017-01-01 - 59 citationsThe PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical ModelsLenka Oplustil O'Connor, Stuart L. Rulten, Aaron Cranston, Rajesh Odedra, Henry Brown
Cancer Research. 2016-10-15 - 175 citationsThe orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in ...Frank P. Vendetti, Alan Lau, Sandra Schamus, Thomas P. Conrads, Mark J. O'Connor
Oncotarget. 2015-10-27